newsfilter
← Latest News
PR Newswire·

Shareholders of YS Biopharma Announce an Extraordinary General Meeting

Shareholders of YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing,...